29 June 2023 in Nature Photonics
4 May 2022 in Journal of the American Chemical Society
21 January 2026 in Proceedings of the National Academy of Sciences
Huntington’s Disease (HD), the most prevalent polyglutamine (polyQ) neurodegenerative disorder, features brain aggregates induced by mutant huntingtin (mHtt) proteins harboring expanded polyQ tracts. Despite extensive efforts, molecular mechanisms of polyQ aggregates remain elusive. Here, we establish quantitative stimulated Raman scattering imaging of polyQ aggregates (q-aggSRS) for noninvasive investigations in live neuronal cocultures using deuterated glutamine labeling. Q-aggSRS allows for specific visualization by targeting the distinct Raman peak from carbon–deuterium bonds, eliminating the need for bulky fluorescent protein tagging (e.g., EGFP). Coupled with analysis from aggregate-tailored expansion microscopy, newly designed two-color imaging, and pulse–chase visualization, we comprehensively quantified the mHtt and non-mHtt proteins within the same aggregates across varying sizes, cell types, mHtt constructs, and subcellular locations. Our findings demonstrate a two-phase aggregate model with a distinct core–shell spatial organization, reveal significant heterogeneity in nucleus/cytoplasm compartmentalization specific to neurons, and identify previously unrecognized loosely packed aggregates specifically in neuronal nuclei. These insights should advance our understanding of native polyQ aggregates, and our proposed interaction coefficients may offer quantitative parameters for developing effective HD therapies.
28 May 2026 in Chemical & Biomedical Imaging
Neuronal metabolism is fundamental to brain functions and diseases, yet its spatial and temporal dynamics and interactions remain poorly understood. Here, we introduce a tandem deep-learning approach integrated with bioorthogonal chemical imaging using stimulated Raman scattering (SRS) microscopy. This method achieves high-speed and quantitative metabolic profiling in live neuronal cocultures. Our deep-learning framework consists of a recurrent convolutional neural network (RCNN) that enables high-resolution 3D imaging with minimal photodamage and a U-Net segmentation model for cell-type-specific metabolic analysis. Using deuterium-labeled metabolites, we demonstrate the ability to trace lipid, protein, glucose, and D2O metabolism in live neurons, astrocytes, and oligodendrocytes under physiological and pathological conditions, including NMDA receptor activation, proteasome inhibition, and Huntington’s disease. Our findings reveal distinct metabolic adaptations among neuronal cell types and underscore the importance of noninvasive metabolic profiling for understanding neuronal interactions and disease mechanisms. This platform significantly advances live-cell dynamic imaging with broad applications in neuroscience, disease modeling, and therapeutic screening.